J&J Management to Discuss Strategy at Morgan Stanley Healthcare Conference

  • Johnson & Johnson (NYSE: JNJ) will present at the Morgan Stanley 24th Annual Global Healthcare Conference on September 14, 2026.
  • Management will participate in a Fireside Chat at 11:30 a.m. Eastern Time.
  • A live audio webcast of the presentation will be accessible through Johnson & Johnson's Investor Relations website.

Johnson & Johnson's participation in the Morgan Stanley Global Healthcare Conference comes at a time when the healthcare sector is undergoing significant transformation, driven by technological advancements and shifting regulatory environments. The company's strategic direction will be closely watched as it navigates these changes to maintain its leadership position.

Strategic Direction
How J&J's management will articulate its strategic priorities in a rapidly evolving healthcare landscape.
Market Positioning
Whether J&J can maintain its competitive edge amid increasing competition and regulatory pressures.
Investor Sentiment
The impact of the conference presentation on investor confidence and stock performance.